Downloads

1. AI Vs. Humans In Novel Drug Target Identification 4/30/2025

   Artificial intelligence is beginning to replace humans in drug discovery, one expert warns — but the industry isn’t ready for the shift.

2. A Checklist For Mechanism-Based Potency Testing In Cell Therapy 4/25/2025

   New research concludes that potency cannot be decoupled from a product's mechanism of action because surrogate markers fail to capture functional relevance.

3. CD34+ HSC LNP Kits 4/24/2025

   Research Use Only (RUO) lipid nanoparticle (LNP) reagents to deliver RNA into hematopoietic stem cells (HSCs) for cell and gene therapy applications.

4. GenVoy-ILM™ T-Cell Kits For mRNA 4/24/2025

   Off-the-shelf, research use only lipid nanoparticle (LNP) reagents to deliver RNA into T-cells.

5. Inside The Development Of An AAV8 Production Platform 4/24/2025

   Explore innovative solutions for AAV8 production challenges, which include scalability and purity, as well as learn how a collaboration with CDMO Matica Biotechnology ensures efficient, high-yield gene therapy vector production.

6. FDA RIFs Might Delay Your Review — Here Are Tips For Mitigating 4/24/2025

   Mounting concerns that FDA reviewers could start missing PDUFA deadlines have put many on edge. The moment calls for defensive and offensive strategies.

7. Promising Clinical Trial Updates Shared At The American Academy Of Neurology Conference 4/24/2025

   The 2025 American Academy of Neurology (AAN) conference in early April saw some promising clinical trial updates treating Guillain-Barre Syndrome and Huntington’s Disease, CIDP, and ALS.

8. Rapid Discovery And Characterization Of Monoclonal Antibodies Against The SARS-CoV-2 Delta Spike Protein 4/23/2025

   Delve into the intricate workflow employed for the discovery and characterization of monoclonal antibodies (mAbs) targeting the Delta spike protein.

9. Fluorescence-Based Technologies For Binding Affinity Studies 4/16/2025

   Reliable binding measurements drive research forward. Explore fluorescence techniques and optimal labeling strategies for sensitive, high-quality data crucial for discovery and cellular studies.

10. Proximity Inducers In Drug Discovery - A Perspective On Cooperativity 4/16/2025

    Overcoming the limitations of current proximity inducers requires optimizing cooperativity. Learn how enhancing target affinity can lead to smaller, more effective therapeutics with better safety profiles.